AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.2800
-0.0400 (-12.50%)
At close: Apr 24, 2026

AccuStem Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5135715-
Market Cap Growth
34.45%157.22%-28.40%-53.62%--
Enterprise Value
5135712-
Last Close Price
0.280.810.450.631.35-
PB Ratio
-1.32-3.84-1.53-3.36-109.68-
Debt / Equity Ratio
-0.01-0.01-0.01-0.03-0.76-
Net Debt / Equity Ratio
0.000.00-0.01-0.024.50-
Net Debt / EBITDA Ratio
0.000.00-0.01-0.020.17-
Net Debt / FCF Ratio
-0.01-0.01-0.03-0.020.35-
Quick Ratio
0.000.000.000.010.681.93
Current Ratio
0.010.010.020.060.861.93
Return on Equity (ROE)
-----1465.96%-68.41%
Return on Assets (ROA)
-137.17%-137.17%-1018.35%-238.76%-204.23%-30.84%
Return on Capital Employed (ROCE)
51.60%51.60%45.40%97.10%2684.60%-103.10%
Earnings Yield
-39.02%-13.43%-29.61%-28.88%-24.48%-
FCF Yield
--6.50%-13.06%-22.76%-11.87%-
Buyback Yield / Dilution
-33.21%-33.21%-0.78%-3.00%-10.17%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.